Orofacial granulomatosis such as CG can be a therapeutic challenge for gastroenterologists and other physicians When CG is accompanied by a major immune-mediated disease, such as inflammatory bowel disease or arthritis, it is reasonable to consider an anti-TNF therapy that will control the major disease and improve and/or heal CG. The gene discussed is TNF; the disease is oroficial granulomatosis.